Progyny, Inc. Announces Third Quarter 2026 Results
Key Highlights
- ➤Revenue $341.3M, up 8.9% year over year
- ➤Net income $26.3M, up from $13.9M; diluted EPS $0.32
- ➤1.3M new covered lives and over 85 new clients secured
- ➤Full-year revenue guidance raised to $1.365B-$1.385B
- ➤Nearly 3M shares repurchased for $82.7M during third quarter
Expert Statements
Pete Anevski, Chief Executive Officer of Progyny
“We're exceptionally pleased with the results of our most recent selling season, where our momentum extended even into its latest stages, yielding 1.3 million new covered lives, our most ever in a single season, and over 85 new clients.”
Pete Anevski, Chief Executive Officer of Progyny
“Beyond new sales activity, our season also focuses on renewing the existing base, where we once again achieved a near 100% retention for 2027 as well as strong demand from those accounts to expand their relationships with us through more comprehensive coverage and the further adoption of our newest services in pregnancy, parenting and menopause support.”
Pete Anevski, Chief Executive Officer of Progyny
“More than ever, these results once again affirm the critical importance of these benefits to employers,”
Pete Anevski, Chief Executive Officer of Progyny
“We believe the energy and success we're seeing reflect how Progyny remains uniquely positioned to consistently deliver meaningful value and cost trend control to employers, which is particularly impactful given the pressures employers are facing from broader medical cost inflation.”
Pete Anevski, Chief Executive Officer of Progyny
“As we look into next year, we believe we're well-positioned to extend this momentum into 2027, as we're exiting the year with our strongest ever set-up in terms of our number of opportunities and the overall size and quality of the pipeline, as our demonstrated ability to effectively bend the cost curve positions us well for continued success.”
Mark Livingston, Chief Financial Officer of Progyny
“We achieved strong top- and bottom-line growth this quarter, reflecting that member engagement was consistent with our expectations, and we are pleased to be in a position to raise the midpoint of our full year guidance.”
Mark Livingston, Chief Financial Officer of Progyny
“In addition to the strong results this quarter, we continued to maintain a high conversion of Adjusted EBITDA to operating cash flow, which has provided us with the flexibility to continue investing in our platform while also returning value to shareholders through the repurchase of nearly 11 million shares this year.”
Reports Record Third Quarter Results for Revenue, Gross Profit, Adjusted EBITDA and Net Income Selling Season Yields Record 1.3 Million New Covered Lives with Another Year of Near 100% Retention Raises Midpoint of Full Year Guidance Ranges
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended September 30, 2026 (“the third quarter of 2026”), as compared to the three-month period ended September 30, 2025 (“the third quarter of 2025” or “the prior year period”).
Get started
Create a free account to read the full story.